Answers are grounded in this paper and cite their sources.
The introduction of anti-inflammatory agents with a lower propensity for GI injury (coxibs) has focused attention on the well-recognized association between prescription nonsteroidal anti-inflammatory drugs (NSAIDs) and GI adverse events. Although over-the-counter (OTC) NSAIDs—including aspirin—are used far more frequently that their prescription counterparts, similar notice has not been paid to their potential health hazards. The Food and Drug Administration approval of low-dose NSAIDs to be sold without a prescription, the long-standing availability of aspirin, and aggressive direct-to-consumer marketing contribute to the lay public's perception of the safety of these drugs. Although data on the GI risks of OTC NSAIDs are emerging, most regular NSAID users lack awareness of their potential side effects (1). The sheer numbers of individuals exposed to OTC agents raise concern regarding their appropriate use.
No takes yet. Share an insight, caveat, or question.
James M. Scheiman (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: